Literature DB >> 19333694

Risk factors of implant exposure outside the conjunctiva after Ahmed glaucoma valve implantation.

Yong Soo Byun1, Na Young Lee1, Chan Kee Park2,3.   

Abstract

PURPOSE: To study possible risk factors in cases in which part of the device becomes exposed outside the conjunctiva after Ahmed glaucoma valve (AGV) implantation.
METHODS: Eleven eyes in which one part of the AGV was exposed outside the conjunctivae were compared with 44 random eyes that underwent the same operation by the same surgeon during the same time period but without any complications. Preoperative diagnosis, age, sex, implant location, number of previous ocular surgeries, and both associated ocular diseases and systemic diseases were taken into account in both the patient group and the control group to determine all possible causes.
RESULTS: Age, implant location, type of glaucoma, diabetes mellitus, and hypertension had no relation to implant exposure. However, the patient group had more ocular surgeries before AGV implantation than the control group (P = 0.006).
CONCLUSION: We found that only the number of previous ocular surgeries was a possible risk factor for implant exposure. More effort should be made to decrease implant exposure outside the conjunctiva, and research should be performed to determine the proper treatment for implant exposure.

Entities:  

Mesh:

Year:  2009        PMID: 19333694     DOI: 10.1007/s10384-008-0630-y

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  19 in total

1.  Clinical results of glaucoma surgery using the White glaucoma pump shunt.

Authors:  T C White
Journal:  Ann Ophthalmol       Date:  1992-10

2.  The use of releasable sutures in Molteno glaucoma implant procedures to reduce postoperative hypotony.

Authors:  F el-Sayyad; A el-Maghraby; M Helal; A Amayem
Journal:  Ophthalmic Surg       Date:  1991-02

3.  Amniotic membrane as an adjunct to donor sclera in the repair of exposed glaucoma drainage devices.

Authors:  Poornima Rai; Roberto Lauande-Pimentel; Keith Barton
Journal:  Am J Ophthalmol       Date:  2005-12       Impact factor: 5.258

4.  A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery.

Authors:  G Ainsworth; A Rotchford; H S Dua; A J King
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

5.  Intermediate-term clinical experience with the Ahmed Glaucoma Valve implant.

Authors:  M C Huang; P A Netland; A L Coleman; S W Siegner; M R Moster; R A Hill
Journal:  Am J Ophthalmol       Date:  1999-01       Impact factor: 5.258

6.  New implant for drainage in glaucoma. Clinical trial.

Authors:  A C Molteno
Journal:  Br J Ophthalmol       Date:  1969-09       Impact factor: 4.638

7.  Initial clinical experience with the Ahmed Glaucoma Valve implant.

Authors:  A L Coleman; R Hill; M R Wilson; N Choplin; R Kotas-Neumann; M Tam; J Bacharach; W C Panek
Journal:  Am J Ophthalmol       Date:  1995-07       Impact factor: 5.258

8.  Valve implants in filtering surgery.

Authors:  T Krupin; S M Podos; B Becker; J B Newkirk
Journal:  Am J Ophthalmol       Date:  1976-02       Impact factor: 5.258

9.  A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma.

Authors:  R S Ayyala; D Zurakowski; J A Smith; R Monshizadeh; P A Netland; D W Richards; W E Layden
Journal:  Ophthalmology       Date:  1998-10       Impact factor: 12.079

10.  Clinical experience with the Baerveldt glaucoma drainage implant.

Authors:  S W Siegner; P A Netland; R C Urban; A S Williams; D W Richards; M A Latina; J D Brandt
Journal:  Ophthalmology       Date:  1995-09       Impact factor: 12.079

View more
  24 in total

1.  Glaucoma drainage devices: risk of exposure and infection.

Authors:  Joshua D Levinson; Annette L Giangiacomo; Allen D Beck; Paul B Pruett; Hillary M Superak; Michael J Lynn; Anastasios P Costarides
Journal:  Am J Ophthalmol       Date:  2015-05-30       Impact factor: 5.258

2.  Treatment of Oculoplastic and Ocular Surface Disease in Eyes Implanted with a Type I Boston Keratoprosthesis in Southern China: A Retrospective Study.

Authors:  Yuying Zhang; Zhancong Ou; Jin Zhou; Jiajie Zhai; Jianjun Gu; Jiaqi Chen
Journal:  Adv Ther       Date:  2020-05-20       Impact factor: 3.845

3.  Clinical outcomes of gamma-irradiated sterile cornea in aqueous drainage device surgery: a multicenter retrospective study.

Authors:  Q Pan; H D Jampel; P Ramulu; G F Schwartz; F Cotter; D Cute; Y J Daoud; P Murakami; W J Stark
Journal:  Eye (Lond)       Date:  2016-11-11       Impact factor: 3.775

4.  Postoperative Complications in the Ahmed Baerveldt Comparison Study During Five Years of Follow-up.

Authors:  Donald L Budenz; William J Feuer; Keith Barton; Joyce Schiffman; Vital P Costa; David G Godfrey; Yvonne M Buys
Journal:  Am J Ophthalmol       Date:  2015-11-18       Impact factor: 5.258

5.  Tenon advancement and duplication technique to prevent postoperative Ahmed valve tube exposure in patients with refractory glaucoma.

Authors:  Nevbahar Tamcelik; Ahmet Ozkok; Ahmet Murat Sarıcı; Eray Atalay; Huseyin Yetik; Kivanc Gungor
Journal:  Jpn J Ophthalmol       Date:  2013-05-24       Impact factor: 2.447

6.  Outcomes of the Shunt Tube Exposure Prevention Study: A Randomized Clinical Trial.

Authors:  Hosam Sheha; Celso Tello; Lama A Al-Aswad; Mohamed S Sayed; Richard K Lee
Journal:  Ophthalmol Glaucoma       Date:  2019-08-16

7.  Tube shunt coverage with gamma-irradiated cornea allograft (VisionGraft).

Authors:  Feyzahan Ekici; Marlene R Moster; Victor Cvintal; Wanda D Hu; Michael Waisbourd
Journal:  Clin Ophthalmol       Date:  2015-05-04

8.  PreserFlo MicroShunt® exposure: a case series.

Authors:  Roxane Bunod; Mathieu Robin; Juliette Buffault; Chafik Keilani; Antoine Labbé; Christophe Baudouin
Journal:  BMC Ophthalmol       Date:  2021-07-10       Impact factor: 2.209

9.  Risk factors for tube shunt exposure: a matched case-control study.

Authors:  Michael S Koval; Fouad F El Sayyad; Nicholas P Bell; Alice Z Chuang; David A Lee; Stephen M Hypes; Davinder S Grover; Laura A Baker; Stephen M Huddleston; Donald L Budenz; Robert M Feldman
Journal:  J Ophthalmol       Date:  2013-07-21       Impact factor: 1.909

10.  Cross-linking as an adjuvant treatment for tectonic corneal lamellar graft preparation.

Authors:  George D Kymionis; Argyro D Plaka; Vasilios F Diakonis; Michael A Grentzelos; Georgios A Kontadakis; Andreana C Mersinoglou; Efstathios T Detorakis; Fotis Topouzis
Journal:  Open Ophthalmol J       Date:  2013-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.